Pediatric Ulcerative Colitis

U.S. FDA Approves SIMPONI® (golimumab) for Pediatric Ulcerative Colitis

October 7, 2025 — Horsham, Pa. — Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has…

56 years ago